2026 Saudi Healthcare M&A · Top Transactions & Themes

Sanabil Investments acquired a strategic stake in Almana General Hospitals to support expansion and institutional governance.

Private investment acquisition of Dr. Abdul Rahman Al-Faqih Hospital to expand bed capacity in Riyadh.

Jada led a $250M investment into major private healthcare & healthtech ventures across the Kingdom.

Continued regional expansion through targeted hospital acquisitions in western and central regions.

Joint ventures & licensing acquisitions to localize biopharma production under Vision 2030 targets.

Large chains (Al Habib, Dallah, Saudi German) acquire smaller clinics, rehab centers, and fertility providers to consolidate market share.

PIF, Sanabil, Jada and regional PE increase capital toward telemedicine, AI diagnostics, and digital health infrastructure.

Driven by SFDA & NUPCO, local producers acquire production lines and licensing agreements from multinational pharma.

Consolidation between Nahdi Medical, Al Dawaa Pharmacies, acquiring independent regional pharmacy networks.